<DOC>
	<DOCNO>NCT00683111</DOCNO>
	<brief_summary>Aspirin clopidogrel +/- heparin thrombolytic co-therapy well establish effective treatment unstable cardiac patient . However , major complication gastrointestinal bleeding ( GIB ) due peptic ulcer . In prevention GIB , anti-ulcer drug either H2-receptor antagonist ( H2RA ) proton pump inhibitor ( PPI ) commonly prescribe . There prospective control study compare efficacy two class anti-ulcer drug .</brief_summary>
	<brief_title>Prevention Gastrointestinal Bleeding Patients With Severe Ischemic Heart Disease</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Famotidine</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>patient admit acute coronary syndrome acute myocardial infarction require active treatment aspirin clopidogrel ( enoxaparin thrombolytic . ) know active peptic ulcer disease gastrointestinal within 8 wk know iron deficiency anemia Hb &lt; 10 gm/dl mechanical ventilation active cancer , liver cirrhosis , endstage renal failure life expectancy &lt; 1 yr know allergic aspirin , clopidogrel , enoxaparin famotidine esomeprazole pregnancy , lactation , childbearing potential absence contraception , coprescription NSAID , corticosteroid , warfarin nonoral feeding impaired GI absorption e.g . vomit already proton pump inhibitor &gt; 1 day another clinical trial drug ulcer disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>acute coronary syndrome</keyword>
	<keyword>acute myocardial infarction</keyword>
	<keyword>aspirin</keyword>
	<keyword>clopidogrel</keyword>
	<keyword>heparin</keyword>
	<keyword>thrombolytic</keyword>
	<keyword>famotidine</keyword>
	<keyword>esomeprazole</keyword>
</DOC>